Scripps Research Institute, Vova Ida Therapeutics patent compounds for treating neurodegeneration July 4, 2022
IAMA reports responses with selective NKCC1 inhibitors in animal models of Down syndrome and autism June 30, 2022
Myelin-forming cells change in multiple brain diseases June 29, 2022 By Anette Breindl Investigators at the Weizmann Institute of Science have identified changes in oligodendrocytes that were shared across multiple dementia types. The team reported its results in the June 27, 2022, online issue of Nature Neuroscience.Read More
RSS
